Registration Options

Activity Dates: 04/17/2023 - 04/17/2026

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

Many psychiatric pharmacists practice in areas where newer or more novel products are not yet adopted. As the field grows, more and more novel delivery systems are likely to come to market, and all psychiatric pharmacists should be familiar with their use. Treatment of the medically ill mental health patient is a challenge that psychiatric pharmacists are often called upon for assistance. When a patient with a severe mental health issue is also facing a complicated medical issue, these novel delivery systems may be an advantage over traditional treatment, especially if a patient is unable to take medications by mouth. This presentation will review the practical use of products with novel delivery systems.

Published Research Related to this Session: 
  • Chapter 3: Alternative Routes of Drug Administration in the Clinical Manual of Psychopharmacology in the Medically Ill, 2nd edition 2017; 3rd edition in press [Crouse EL, Leung JG, Adams KS, Levenson JL)
  • Chapter 36: Psychopharmacology in The American Psychiatric Association Publishing Textbook of Psychosomatic Medicine and Consultation-Liaison Psychiatry, 3rd edition. 2019, APA [Owens JA, Crouse EL, Kirkwood CKK, Levenson JL]
  • Chapter 27: Levenson JLL, Crouse EL, Bozymski K. “Psychopharmacology” in The American Psychiatric Association Publishing Textbook of Psychiatry. Seventh Edition. 2019., American Psychiatric Association Publishing, Washington DC.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Ericka L. Crouse, PharmD, BCPP, BCGP

View biographical information and disclosures

Learning Objectives

  1. Evaluate the pharmacokinetics and pharmacodynamics of novel delivery systems of psychotropic drugs. 
  2. Compare and/or contrast use and safety of novel delivery systems with traditional delivery systems.
  3. Recommend strategies to adopt novel delivery systems into current practice.

Continuing Education Credit and Disclosures

Activity Dates: 04/17/2023 - 04/17/2026
ACPE Contact Hours: 1
ACPE Number: 0284-0000-23-007-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.